Machine signal
Active cluster sell — 3 distinct insiders, $13M, window ends Oct 5, 2026.
Figures computed from official regulatory filings — .
Analysttarget 65.38 USD (+5%) · consensus 4.5/5 · 7 buy · 1 hold · 0 sell
Ownershipinsiders 6.49% · institutions 87.66% · short 2.9% of float
In USD · as of Oct 19, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Royalty Pharma plc only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company has research and development funding collaboration to advance the development of JNJ-4804, an investigational medicine for autoimmune diseases. The company was founded in 1996 and is based in New York, New York.
Market information source · Oct 19, 2026
SEC company identity · Oct 19, 2026
Open-market timeline · full history
19 buys262 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Urist Marshall | Sell | $235.6K | Unusual size | SEC |
| Bassler Bonnie L | Award | $37.5K | SEC |
| Urist Marshall | Sell | $238.8K | Unusual size | SEC |
| Hite Christopher | Sell | $231.4K | SEC |
| Hite Christopher | Sell | $5.6M | SEC |
| Hite Christopher | Gift | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Hite Christopher | Sell | $6M | SEC |
| Coyne Terrance P. | Sell | $540.8K | SEC |
| Coyne Terrance P. | Sell | $104.8K | SEC |
| Coyne Terrance P. | GiftD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Urist Marshall | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Urist Marshall | GiftD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Legorreta Pablo G.track record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Coyne Terrance P. | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Legorreta Pablo G.track record | GiftD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Hite Christopher | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Urist Marshall | Sell | $508.5K | SEC |
| Hite Christopher | Sell | $34.3K | SEC |
| Hite Christopher | Sell | $145.8K | SEC |
| Hite Christopher | Sell | $1.7M | SEC |
| Hite Christopher | Sell | $5.5M | SEC |
| Bassler Bonnie L | Award | $37.5K | SEC |
| Hite Christopher | Sell | $6.4M | SEC |
| Urist Marshall | Sell | $502.1K | SEC |
| Hite Christopher | Sell | $1.8M | SEC |